Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccines, Pneumococcal Conjugate Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01732198
What this trial is testing

A Phase 2, Multicenter, Open-label Study to Assess the Immunogenicity of an Investigational Hib Vaccine (NU300)in Toddlers

Who this might be right for
Infectious Disease
Nuron Biotech Inc. 220
Early research (Phase 1)Study completedNCT06698198
What this trial is testing

Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine Candidate in Healthy Adults (19-49 Years)

Who this might be right for
Pneumococcal Immunization
Sanofi Pasteur, a Sanofi Company 175
Testing effectiveness (Phase 2)Study completedNCT00513409
What this trial is testing

Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 163
Large-scale testing (Phase 3)Looking for participantsNCT06608199
What this trial is testing

Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfizer's PCV13 Vaccine

Who this might be right for
Pneumococcal VaccinesPneumococcal Infections
Beijing Minhai Biotechnology Co., Ltd 500
Post-approval studies (Phase 4)Study completedNCT02062281
What this trial is testing

Study of Evaluating Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine With Influenza Vaccine in Children and Adults

Who this might be right for
Pneumococcal InfectionInfluenza
Jiangsu Province Centers for Disease Control and Prevention 2,225
Post-approval studies (Phase 4)Study completedNCT05175014
What this trial is testing

Mass Campaigns With Fractional Dose Pneumococcal Vaccines in Sub-Saharan Africa (fPCV)

Who this might be right for
Pneumococcal Carriage
Epicentre 44,618
Post-approval studies (Phase 4)UnknownNCT00152802
What this trial is testing

Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate Vaccine

Who this might be right for
Transplant
University Health Network, Toronto 130
Not applicableStudy completedNCT01425372
What this trial is testing

Evaluating Vaccine Responses in Healthy Infants Receiving Their Routine Primary Immunisation According to the Accelerated United Kingdom Schedule at 2, 3 and 4 Months

Who this might be right for
Streptococcus Pneumoniae
Prof. Elizabeth Miller 93
Testing effectiveness (Phase 2)Study completedNCT00307567
What this trial is testing

Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488

Who this might be right for
Acellular PertussisTetanusHepatitis B+3 more
GlaxoSmithKline 689
Testing effectiveness (Phase 2)Study completedNCT00170612
What this trial is testing

Pneumococcal Vaccination of Fiji Infants

Who this might be right for
Pneumococcal Infections
University of Melbourne 552
Not applicableStudy completedNCT01128426
What this trial is testing

Postlicensure Observational Safety Study of 13vPnC Administered to Infants and Toddlers

Who this might be right for
Pneumococcal Disease
Pfizer 53,902
Large-scale testing (Phase 3)Ended earlyNCT00119743
What this trial is testing

A Efficacy Against Otitis Media in Children With 11 Valent Pneumococcal Vaccine

Who this might be right for
Hepatitis A
GlaxoSmithKline 5,000
Large-scale testing (Phase 3)Study completedNCT03893448
What this trial is testing

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)

Who this might be right for
Pneumococcal InfectionsPneumococcal Vaccines
Merck Sharp & Dohme LLC 1,720
Large-scale testing (Phase 3)Study completedNCT00963235
What this trial is testing

Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS

Who this might be right for
HIV InfectionsPneumococcal Infections
Pfizer 331
Large-scale testing (Phase 3)Study completedNCT04278248
What this trial is testing

Immunogenicity and Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Healthy Volunteers Aged 2 Years and Above

Who this might be right for
Pneumonia, Pneumococcal
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 1,940
Not applicableUnknownNCT02012309
What this trial is testing

Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses

Who this might be right for
HIVPneumococcal InfectionsPneumococcal Vaccines
University of Colorado, Denver 60
Large-scale testing (Phase 3)Study completedNCT02447432
What this trial is testing

Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 320
Post-approval studies (Phase 4)Study completedNCT01735084
What this trial is testing

Using Pneumococcal Vaccines in Combination for Maximum Protection From Ear and Lung Infections in First 3 Years of Life

Who this might be right for
Otitis MediaFebrile IllnessCough+2 more
Menzies School of Health Research 261
Early research (Phase 1)Study completedNCT01995617
What this trial is testing

Safety and Immunogenicity Study of Prophylactic Streptococcus Pneumoniae Vaccine

Who this might be right for
Streptococcus Pneumoniae
Genocea Biosciences, Inc. 90
Early research (Phase 1)Study completedNCT05831124
What this trial is testing

Learn About a Type of Pneumococcal Vaccine With a New Ingredient (PF-07872411) Intended to Enhance the Effects of the Vaccine Which is Given to Adults

Who this might be right for
Pneumococcal Disease
Pfizer 90
Next Page